Skip to main content
EJNMMI Research
Fig. 3 | EJNMMI Research

Fig. 3

From: Added value of 68Ga-PSMA PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer and a previous 99mTc bone scintigraphy

Fig. 3

Example of a patient (PSA 6 ng/mL, Gleason score 7, T2b) with four equivocal lesions according to BS (shown in anterior projection) (a) including a lesion in the fourth right rib indicated by the arrow. According to the 68Ga-PSMA-11 PET/CT, the lesion was considered metastatic as shown by the 68Ga-PSMA-11 MIP (b) with the corresponding axial 68Ga-PSMA-11 PET (c), PET/CT fusion (d), and a slight sclerotic lesion in the axial CT image (e). Except for the high 68Ga-PSMA-11 uptake in the prostate, no other suspicious lesions were observed. The patient underwent a CT-guided biopsy that showed benign findings, and then the patient had a radical prostatectomy without any systemic treatment. The PSA dropped to < 0.1 ng/mL after prostatectomy and remained so for at least 12 months

Back to article page